These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3186685)
21. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas. Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631 [TBL] [Abstract][Full Text] [Related]
22. Effect of a specific serine protease inhibitor on the rat pancreas. II. Influence of camostate on the endocrine pancreas. Göke B; Siegel EG; Stöckmann F; Lankisch PG; Creutzfeldt W Digestion; 1985; 31(2-3):128-35. PubMed ID: 3888752 [TBL] [Abstract][Full Text] [Related]
23. Stimulation of pancreatic secretory process in the rat by low-molecular weight proteinase inhibitor. III. Changes in DNA synthesis and mitotic activity. Elsässer HP; Puplat D; Adler G; Kern HF Cell Tissue Res; 1990 Oct; 262(1):143-8. PubMed ID: 2257606 [TBL] [Abstract][Full Text] [Related]
24. Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini. Otsuki M; Fujii M; Nakamura T; Tani S; Okabayashi Y Int J Pancreatol; 1995 Oct; 18(2):135-43. PubMed ID: 8530829 [TBL] [Abstract][Full Text] [Related]
25. Role of ornithine decarboxylase and polyamines in camostate (Foy-305)-induced pancreatic growth in rats. Löser C; Fölsch UR; Cleffmann U; Nustede R; Creutzfeldt W Digestion; 1989; 43(1-2):98-112. PubMed ID: 2509268 [TBL] [Abstract][Full Text] [Related]
26. Subcutaneous administration of the synthetic trypsin inhibitor Foy-305 induces hypertrophy of the exocrine pancreas. Wereszczyńska-Siemiatkowska U; Pohl U; Otto J; Lankisch PG Digestion; 1987; 37(3):144-8. PubMed ID: 2443410 [TBL] [Abstract][Full Text] [Related]
27. Endocrine and exocrine pancreatic function after camostate-induced growth of the organ. von Schönfeld J; Rünzi M; Goebell H; Müller MK Experientia; 1995 Jun; 51(6):556-60. PubMed ID: 7607295 [TBL] [Abstract][Full Text] [Related]
28. [Study on the trophic effect of camostate mesilate on ethionine-induced pancreatic injury rat]. Oishi T; Nakagawa M; Bamba T; Hosoda S Nihon Shokakibyo Gakkai Zasshi; 1989 May; 86(5):1125-35. PubMed ID: 2477572 [TBL] [Abstract][Full Text] [Related]
29. Stimulation of pancreatic secretion in man by a protease inhibitor (camostate). Adler G; Müllenhoff A; Koop I; Bozkurt T; Göke B; Beglinger C; Arnold R Eur J Clin Invest; 1988 Feb; 18(1):98-104. PubMed ID: 3130267 [TBL] [Abstract][Full Text] [Related]
30. Chronic effects of camostate on growth and endocrine function of the pancreas in streptozotocin-induced diabetic rats. Kogire M; Inoue K; Gu Y; Uchida K; Imamura M Proc Soc Exp Biol Med; 1993 Nov; 204(2):201-5. PubMed ID: 8415777 [TBL] [Abstract][Full Text] [Related]
31. Acute and chronic effects of cyclosporine A on pancreatic polyamine metabolism and pancreatic adaptation. Löser C; Alves F; Stöckmann F; Fölsch UR; Creutzfeldt W Digestion; 1990; 46 Suppl 2():367-77. PubMed ID: 2262069 [TBL] [Abstract][Full Text] [Related]
32. Secretory responses of hypertrophied rat pancreas induced by repeated oral administrations of a synthetic protease inhibitor. Yonezawa H Jpn J Physiol; 1983; 33(2):183-95. PubMed ID: 6876500 [TBL] [Abstract][Full Text] [Related]
33. Ornithine decarboxylase and polyamine biosynthesis in pancreatic adaptation. Löser C; Cleffmann U; Alves F; Fölsch UR; Creutzfeldt W Adv Exp Med Biol; 1988; 250():379-88. PubMed ID: 3255234 [TBL] [Abstract][Full Text] [Related]
34. Different effects of trypsin inhibitors on intestinal gene expression of secretin and on pancreatic bicarbonate secretion in CCK-A-receptor-deficient rats. Kawanami T; Suzuki S; Yoshida Y; Kanai S; Takata Y; Shimazoe T; Watanabe S; Funakoshi A; Miyasaka K Jpn J Pharmacol; 1999 Dec; 81(4):339-45. PubMed ID: 10669038 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster. Douglas BR; Woutersen RA; Jansen JB; Rovati LC; Lamers CB Life Sci; 1990; 46(4):281-6. PubMed ID: 2304371 [TBL] [Abstract][Full Text] [Related]
36. Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats. Otsuki M; Tani S; Okabayashi Y; Fuji M; Nakamura T; Fujisawa T; Itoh H Dig Dis Sci; 1990 Feb; 35(2):242-50. PubMed ID: 1689237 [TBL] [Abstract][Full Text] [Related]
37. Endogenous somatostatin possibly controls pancreatic growth: further evidence for feedback regulation. Rünzi M; Müller MK; Goebell H Regul Pept; 1993 Aug; 47(1):65-72. PubMed ID: 8105514 [TBL] [Abstract][Full Text] [Related]
38. Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion. Adler G; Reinshagen M; Koop I; Göke B; Schafmayer A; Rovati LC; Arnold R Gastroenterology; 1989 Apr; 96(4):1158-64. PubMed ID: 2647576 [TBL] [Abstract][Full Text] [Related]
39. Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves. Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Drozdowicz D; Kwiecień S; Hahn EG Regul Pept; 1999 Jun; 82(1-3):19-33. PubMed ID: 10458643 [TBL] [Abstract][Full Text] [Related]
40. Adaptation of the human pancreas to inhibition of luminal proteolytic activity. Friess H; Kleeff J; Isenmann R; Malfertheiner P; Büchler MW Gastroenterology; 1998 Aug; 115(2):388-96. PubMed ID: 9679044 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]